Clinical Trials
22 trialsNCT04784715 2026-05-22
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
AstraZeneca
Phase 3 Active not recruiting
NCT05768139 2026-05-22
PIKALO-1
Eli Lilly and Company
Phase 1/2 Recruiting
NCT05006196 2026-05-20
IMOGEN
Perspectum
Active not recruiting
NCT07581834 2026-05-12
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06993844 2026-05-06
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Phase 1/2 Recruiting
NCT04964934 2026-04-21
SERENA-6
AstraZeneca
Phase 3 Active not recruiting
NCT05386108 2026-04-06
ELECTRA
Stemline Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07505797 2026-04-01
AUDIBLE
iSono Health, Inc.
Recruiting
NCT07500428 2026-03-30
BUST-AI Bench
Peking Union Medical College Hospital
Recruiting
NCT03709446 2026-03-19
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT07038369 2026-03-17
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Phase 1 Active not recruiting
NCT05720039 2026-02-24
SP NSM
Intuitive Surgical
Phase NA Active not recruiting
NCT06780176 2026-02-06
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
Memorial Sloan Kettering Cancer Center
Recruiting
NCT04854304 2026-01-15
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT07313514 2026-01-02
MMO
University Hospital, Strasbourg, France
Recruiting
NCT04711252 2025-10-14
SERENA-4
AstraZeneca
Phase 3 Active not recruiting
NCT06335069 2025-09-24
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Maastricht University Medical Center
Phase 2 Recruiting
NCT07010939 2025-09-12
PERSEVERE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
NCT06886659 2025-07-22
A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)
Incepta Pharmaceuticals Ltd
Phase 1 Completed
NCT03304080 2025-07-18
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
Icahn School of Medicine at Mount Sinai
Phase 1/2 Active not recruiting
NCT06187350 2025-06-06
AIM-RÖ
Ostergotland County Council, Sweden
Completed
NCT04774471 2025-06-03
Advanced Diffusion Tensor MRI for Breast Cancer
Endeavor Health
Completed